Drug Reference

Mupirocin (Topical)

Mupirocin calcium

Brand names:Bactroban, Centany

AntibioticTCCC Doctrine

A topical antibiotic with strong activity against Staphylococcus aureus including MRSA, used for impetigo, minor skin infections, and nasal MRSA decolonization. Mupirocin is operationally important in tactical and deployment medicine where MRSA carriage in close-quarters environments is a real concern.

Mission Capable - No Impact

Administration does not impair the recipient's ability to remain operational. Standard mission performance is preserved at therapeutic doses.

Pharmacology and Actions

Mupirocin inhibits bacterial protein synthesis by binding to isoleucyl-tRNA synthetase, blocking incorporation of isoleucine into bacterial proteins. The mechanism is unique among topical antibiotics, which means cross-resistance with other antibiotics is uncommon. Spectrum is focused on gram-positive cocci, particularly Staphylococcus aureus (including MRSA) and Streptococcus pyogenes. Activity against gram-negative organisms is minimal.

Indications

  • Impetigo and other superficial skin infections caused by susceptible Staphylococcus or Streptococcus
  • Nasal decolonization of MRSA carriers (tactical team operational health)
  • Minor wound infections in close-quarters living environments
  • Adjunct to systemic therapy for recurrent skin and soft tissue MRSA infections

Absolute Contraindications

  • Known mupirocin allergy
  • Burns covering large body surface areas
  • Application to open wounds with significant systemic absorption potential

Precautions and Side Effects

Generally well tolerated topically. Local irritation, burning, stinging, and itching at application site can occur. Contact dermatitis is rare. Systemic absorption is minimal with intact skin but increases with extensive open wounds or burns. The polyethylene glycol vehicle in some preparations can be absorbed in large amounts from burned skin and cause renal toxicity. Resistance can develop with prolonged or repeated use, particularly in MRSA decolonization protocols.

Pediatric Dosing

Topical pediatric dosing same as adult, applied sparingly. Approved for impetigo in patients 2 months and older.

Pharmacokinetics

Peak Effect: Topical: localized antibacterial effect within minutes of application

Duration: 8 hours per application; supports TID dosing

Storage and Handling

Store at controlled room temperature (15 to 30 degrees Celsius). Protect from heat extremes. Nasal preparation is supplied in single-use tubes for hygiene; do not share tubes between team members.

Reconstitution:

Topical ointment and nasal preparation require no reconstitution.

TCCC and TECC Role

Mupirocin is not a primary TCCC wound prophylaxis agent but has operational value in tactical settings for MRSA decolonization in team members who are recurrent carriers, and for treating impetigo and minor skin infections that arise in close-quarters living environments. The drug is particularly relevant in deployment settings, training facilities, and other shared-living environments where MRSA carriage and transmission are operational concerns.

Field Context

Mupirocin is the drug that addresses the operational reality of MRSA in close-quarters tactical and military environments. Nasal decolonization protocols (Bactroban Nasal twice daily for 5 days, combined with chlorhexidine showers) can interrupt outbreaks in team housing and training facilities. For active skin infections, mupirocin is most useful in superficial impetigo and minor folliculitis; deeper infections require systemic antibiotics. Resistance is a real concern with repeated use, so reserve mupirocin for indicated use rather than as a routine topical wound dressing.

Common Mistake

Using mupirocin as a general topical antibiotic for wound care. The drug has narrow indications (superficial skin infection, MRSA decolonization) and resistance develops with overuse. For minor cuts and abrasions where topical antibiotic is appropriate, bacitracin or a triple-antibiotic combination is the better choice. Reserve mupirocin for documented or strongly suspected staphylococcal indications.

Clinical Reference Notice

This drug profile is provided as educational reference material for trained medical providers. It is not medical advice, not a substitute for formal training, and not a substitute for current published guidelines or medical direction.

Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances are subject to additional handling, accountability, and documentation requirements per DEA and state law. Always verify dosing, indications, contraindications, and route of administration against current published guidelines and your local protocols before administration.

If this content is being viewed during a medical emergency, call 911 immediately and follow the direction of your local emergency dispatch and medical control. Do not use this reference as a substitute for emergency medical services.

Drug information evolves. Last reviewed dates and source citations are provided for each entry. Confirm currency against the cited source before clinical use.

Penn Tactical Solutions publishes this reference for educational purposes. PTS does not provide medical direction and does not assume responsibility for clinical decisions made in the field. Clinical responsibility rests with the administering provider, their medical director, and their agency.

Educational reference for trained medical providers. Not medical advice. Not a substitute for formal training, current published guidelines, or medical direction. Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances require additional storage, accountability, and documentation per DEA and state law.

In a medical emergency, call 911. This reference is not a substitute for emergency medical services.

Verify dosing, indications, and contraindications against current published guidelines and your local protocols before administration. Confirm content currency against the source citation. Penn Tactical Solutions does not provide medical direction. Clinical responsibility rests with the administering provider, their medical director, and their agency.

Mupirocin (Topical)

Mupirocin calcium
Antibiotic
Mission Capable - No Impact
Pediatric
Topical pediatric dosing same as adult, applied sparingly. Approved for impetigo in patients 2 months and older.
Contraindications
Known mupirocin allergy| Burns covering large body surface areas| Application to open wounds with significant systemic absorption potential
Common Mistake
Using mupirocin as a general topical antibiotic for wound care. The drug has narrow indications (superficial skin infection, MRSA decolonization) and resistance develops with overuse. For minor cuts and abrasions where topical antibiotic is appropriate, bacitracin or a triple-antibiotic combination is the better choice. Reserve mupirocin for documented or strongly suspected staphylococcal indications.